The FDA approves Sunharbo, a new factor XIa inhibitor, to reduce the risk of another ischemic stroke in certain adults following a stroke or high-risk mini-stroke.
FDA Approves Sunharbo, First Factor XIa Inhibitor for Secondary Stroke Prevention
The FDA approves Sunharbo, a new factor XIa inhibitor, to reduce the risk of another ischemic stroke in certain adults following a stroke or high-risk mini-stroke.